Pages that link to "Item:Q3800950"
From MaRDI portal
The following pages link to Evaluation of Sample Size and Power for Analyses of Survival with Allowance for Nonuniform Patient Entry, Losses to Follow-Up, Noncompliance, and Stratification (Q3800950):
Displaying 10 items.
- Optimal treatment allocation and study duration for trials with discrete-time survival endpoints (Q1937208) (← links)
- On lachin'S formulae for sample sizes of survival tests (Q3135333) (← links)
- Calculation of Sample Size in Survival Trials: The Impact of Informative Noncompliance (Q3445311) (← links)
- Sample Size Estimation for Survival Outcomes in Cluster‐Randomized Studies with Small Cluster Sizes (Q4667491) (← links)
- Information and information fractions for design and sequential monitoring of clinical trials (Q4843737) (← links)
- Heterogeneous treatment effects in stratified clinical trials with time‐to‐event endpoints (Q5348691) (← links)
- Sample size calculations for noninferiority trials for time-to-event data using the concept of proportional time (Q5861550) (← links)
- On the empirical choice of the time window for restricted mean survival time (Q6047753) (← links)
- Sample size estimation for cancer randomized trials in the presence of heterogeneous populations (Q6055721) (← links)
- Sample size calculation for two‐arm trials with time‐to‐event endpoint for nonproportional hazards using the concept of Relative Time when inference is built on comparing Weibull distributions (Q6085898) (← links)
